CN1395579A - 含α－D－GAL(1→3)GAL的寡糖的合成方法 - Google Patents

含α－D－GAL(1→3)GAL的寡糖的合成方法 Download PDF

Info

Publication number
CN1395579A
CN1395579A CN01803721A CN01803721A CN1395579A CN 1395579 A CN1395579 A CN 1395579A CN 01803721 A CN01803721 A CN 01803721A CN 01803721 A CN01803721 A CN 01803721A CN 1395579 A CN1395579 A CN 1395579A
Authority
CN
China
Prior art keywords
benzyl
benzoyl
compound
ethanoyl
acetamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01803721A
Other languages
English (en)
Chinese (zh)
Inventor
劳伦特·博奈
久洛·戴卡尼
尼古拉斯·巴里·德南
约翰·帕帕耶奥尔尤
迈克尔·利奥·韦斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alchemia Pty Ltd
Original Assignee
Alchemia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ5073A external-priority patent/AUPQ507300A0/en
Priority claimed from AUPQ9734A external-priority patent/AUPQ973400A0/en
Application filed by Alchemia Pty Ltd filed Critical Alchemia Pty Ltd
Publication of CN1395579A publication Critical patent/CN1395579A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN01803721A 2000-01-13 2001-01-12 含α－D－GAL(1→3)GAL的寡糖的合成方法 Pending CN1395579A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPQ5073 2000-01-13
AUPQ5073A AUPQ507300A0 (en) 2000-01-13 2000-01-13 Methods for synthesis of alpha-d-gal(1-3) gal containing oligosaccharides
AUPQ9734 2000-08-29
AUPQ9734A AUPQ973400A0 (en) 2000-08-29 2000-08-29 Methods for synthesis of alpha-d-gal(1-3) gal containing oligosaccharides

Publications (1)

Publication Number Publication Date
CN1395579A true CN1395579A (zh) 2003-02-05

Family

ID=25646242

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01803721A Pending CN1395579A (zh) 2000-01-13 2001-01-12 含α－D－GAL(1→3)GAL的寡糖的合成方法

Country Status (8)

Country Link
US (1) US20040058888A1 (enExample)
EP (1) EP1257558A1 (enExample)
JP (1) JP2003519628A (enExample)
CN (1) CN1395579A (enExample)
CA (1) CA2396966A1 (enExample)
HU (1) HUP0204225A2 (enExample)
IL (1) IL150410A0 (enExample)
WO (1) WO2001051499A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102977159A (zh) * 2012-11-18 2013-03-20 大连九信生物化工科技有限公司 一种苄醚保护d-氨基葡萄糖衍生物c3位上羟基的制备方法
CN114423773A (zh) * 2019-07-25 2022-04-29 西纳福克斯股份有限公司 6-叠氮基-6-脱氧-2-n-乙酰基-己糖胺-核苷二磷酸的合成

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR079700A0 (en) * 2000-10-17 2000-11-09 Alchemia Pty Ltd Combinatorial libraries of monosaccharides
AUPS213802A0 (en) 2002-05-03 2002-06-06 Alchemia Pty Ltd Disaccharides for drug discovery
AU2002952121A0 (en) 2002-10-17 2002-10-31 Alchemia Limited Novel carbohydrate based anti-bacterials
US7847019B2 (en) * 2007-10-15 2010-12-07 California Institute Of Technology Functionalized polymers using protected thiols
EP2987503A1 (en) * 2014-08-22 2016-02-24 Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Methods and reagents for prevention and/or treatment of infection
CN113416220B (zh) * 2021-06-24 2023-07-18 宁波职业技术学院 一种硫代葡萄糖类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5651968A (en) * 1991-08-23 1997-07-29 Alberta Research Council Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
ATE304865T1 (de) * 1998-04-15 2005-10-15 Mayo Foundation Hemmung xenoreaktiver antikörper

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102977159A (zh) * 2012-11-18 2013-03-20 大连九信生物化工科技有限公司 一种苄醚保护d-氨基葡萄糖衍生物c3位上羟基的制备方法
CN114423773A (zh) * 2019-07-25 2022-04-29 西纳福克斯股份有限公司 6-叠氮基-6-脱氧-2-n-乙酰基-己糖胺-核苷二磷酸的合成

Also Published As

Publication number Publication date
CA2396966A1 (en) 2001-07-19
WO2001051499A1 (en) 2001-07-19
HUP0204225A2 (en) 2003-05-28
JP2003519628A (ja) 2003-06-24
EP1257558A1 (en) 2002-11-20
US20040058888A1 (en) 2004-03-25
IL150410A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
JP4553488B2 (ja) カルボキシメチルガラクトース誘導体
EP2949665B1 (en) Glycosylation atrial natriuretic peptide
US9540409B2 (en) Synthetic amphiphiles for membrane protein manipulation
JP2588729B2 (ja) スフィンゴシン誘導体
US20110245488A1 (en) Process for the synthesis of l-fucosyl di- or oligo-saccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
JPH11510490A (ja) ルイスｙエピトープの複合糖質の合成及びこれらの使用
WO2005118625A1 (en) Triazole-linked glycoamino acids and glycopeptides
CN1281615C (zh) 从9a－氮杂大环内酯类衍生的新3,6－半缩酮类
EP2417145A1 (en) 6"-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides
CN1395579A (zh) 含α－D－GAL(1→3)GAL的寡糖的合成方法
CN1151795C (zh) 含(磺基吡喃糖基)酰基甘油衍生物的药品
CN1051090C (zh) 用氟取代唾液酸的9位的神经节苷脂gm3类似物
CN1248976A (zh) 带保护基的氨基糖
JP4599295B2 (ja) α−選択的グリコシル化反応方法
JP2001504460A (ja) １―ガラクトース誘導体
Kosma et al. Synthesis of neoglycoproteins containing Kdo epitopes specific for Chlamydophila psittaci lipopolysaccharide
AU2654201A (en) Methods for synthesis of alpha-D-GAL (1-3) GAL-containing oligosaccharides
JPH07224082A (ja) アスパラギン結合型糖誘導体及びその製法
JPH0649099A (ja) 糖鎖関連抗原誘導体
JP4336907B2 (ja) シアル酸誘導体
JP2002503668A (ja) Ｇｍ３を合成する方法
JP4813838B2 (ja) コア６型構造を有するｏ−結合型糖アミノ酸誘導体およびその製造方法
WO2003106473A1 (ja) グルコシルリピッドa1位カルボキシメチル類縁体
JP2001509777A (ja) グルコサミニルムラミン酸誘導体の調製
JPH09510203A (ja) α−Ｎ−アセチルガラクトサミニドの合成のための立体特異方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication